跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Olmesartan/HCT Sandoz 20/12.5 olmesartan medoxomil/hydrochlorothiazide 20/12.5 mg film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
Olmesartan/HCT Sandoz 20/12.5 olmesartan medoxomil/hydrochlorothiazide 20/12.5 mg film-coated tablet blister pack
Approved
STANDARD
Olmesartan/HCT Sandoz 20/12.5 olmesartan medoxomil/hydrochlorothiazide 20/12.5 mg film-coated tablet blister pack
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
d71aa0912f4e2866
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
d71aa0912f4e2866
Product Name
Olmesartan/HCT Sandoz 20/12.5 olmesartan medoxomil/hydrochlorothiazide 20/12.5 mg film-coated tablet blister pack
Artg Id
221119
Artg Name
Olmesartan/HCT Sandoz 20/12.5 olmesartan medoxomil/hydrochlorothiazide 20/12.5 mg film-coated tablet blister pack
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2015-02-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/543c9014e9347935a93efc7cb3087dcb.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/f9f3b11e0c8cacb25fcb5ba3ef55fbd7.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
d71aa0912f4e2866
Type
Standard
Back to TGA Approvals